Table 3

Treatments and outcomes for infants ≥32 weeks gestation who received assisted ventilation for ≥4 hours

Treatments and outcomes32–33 weeks (n=474)34–36 weeks (n=626)37–38 weeks (n=285)39–40 weeks (n=313)>40 weeks (n=174)All ≥32 (n=1872)
Data are presented as n (%) or as median (25th,75th centiles) and exclude infants ≥32 weeks who had major surgery.
*For infants who received this treatment and survived to go home.
†For infants who received IPPV.
‡For infants who survived to go home.
IPPV, Intermittent positive pressure ventilation; CPAP, continuous positive airways pressure; PMA, postmenstrual age.
Reason for respiratory support
    Hyaline membrane disease182 (41)211 (37)51 (20)14 (5)10 (6)468 (27)
    Non-specific respiratory distress189 (43)251 (44)99 (38)89 (30)37 (22)665 (38)
    Pneumonia20 (5)40 (7)35 (13)42 (14)15 (9)152 (9)
    Newborn encephalopathy3 (1)3 (1)13 (5)23 (8)12 (7)54 (3)
    Pulmonary hypertension2 (0)6 (1)8 (3)24 (8)10 (6)50 (3)
    Meconium aspiration0 (0)1 (0)12 (5)57 (19)54 (32)124 (7)
    Congenital malformation3 (1)11 (2)9 (3)16 (5)9 (5)48 (3)
Mode of assisted ventilation
    IPPV + CPAP74 (16)85 (14)50 (18)45 (14)35 (20)289 (15)
    CPAP only375 (79)507 (81)205 (72)212 (68)116 (67)1415 (76)
    IPPV only25 (5)34 (5)30 (11)56 (18)23 (13)168 (9)
Days of assisted ventilation*2 (1,4)2 (1,4)2 (1,4)1 (1,2)2 (1,3)2 (1,4)
Days of supplemental oxygen*2 (1,4)3 (1,5)3 (1,5)2 (1,4)2 (1,4)2 (1,5)
Respiratory treatments†
    High frequency ventilation5 (5)4 (3)1 (1)7 (7)5 (9)22 (5)
    Nitric oxide5 (5)8 (7)16 (20)21 (21)28 (48)78 (17)
Air leak requiring drainage14 (3)31 (5)22 (9)14 (5)9 (5)90 (5)
Survived to discharge home470 (99)620 (99)273 (96)284 (91)165 (95)1812 (97)
Length of stay (days)‡26 (22,34)15 (11,20)9 (6,12)7 (5,10)7 (5,11.5)14 (8,24)
PMA at discharge home (weeks)‡36.3 (35.6,37.3)37.1 (36.6,37.7)38.9 (38.3,39.4)40.9 (40.4,41.1)42.4 (41.9,43.0)37.9 (36.6,40.1)